1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. US Esoteric Testing Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. US Esoteric Testing Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. US Esoteric Testing Market Country Analysis
6.2 US Esoteric Testing Market Revenue 2020-2030 (US$ Billion)
6.3 US Esoteric Testing Market Forecast Analysis
7. US Esoteric Testing Market Analysis – by Type
7.1 Infectious Disease Testing
- 7.1.1 Overview
- 7.1.2 Infectious Disease Testing: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
7.2 Endocrinology Testing
- 7.2.1 Overview
- 7.2.2 Endocrinology Testing: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
7.3 Oncology Testing
- 7.3.1 Overview
- 7.3.2 Oncology Testing: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
7.4 Toxicology Testing
- 7.4.1 Overview
- 7.4.2 Toxicology Testing: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
7.5 Immunology Testing
- 7.5.1 Overview
- 7.5.2 Immunology Testing: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
7.6 Neurology Testing
- 7.6.1 Overview
- 7.6.2 Neurology Testing: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
8. US Esoteric Testing Market Analysis – by Technology
8.1 Chemiluminescence Immunoassay
- 8.1.1 Overview
- 8.1.2 Chemiluminescence Immunoassay: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
8.2 Enzyme-Linked Immunosorbent Assay
- 8.2.1 Overview
- 8.2.2 Enzyme-Linked Immunosorbent Assay: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
8.3 Mass Spectrometry
- 8.3.1 Overview
- 8.3.2 Mass Spectrometry: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
8.4 Real-Time PCR
- 8.4.1 Overview
- 8.4.2 Real-Time PCR: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
8.5 DNA Sequencing
- 8.5.1 Overview
- 8.5.2 DNA Sequencing: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
8.6 Flow Cytometry
- 8.6.1 Overview
- 8.6.2 Flow Cytometry: US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
9. US Esoteric Testing Market Analysis – by End User
9.1 Hospitals & Laboratories and Independent & Reference Laboratories
- 9.1.1 Overview
- 9.1.2 Hospitals & Laboratories and Independent & Reference Laboratories : US Esoteric Testing Market – Revenue and Forecast, 2020-2030 (US$ Billion)
10. US Esoteric Testing Market – United States Analysis
10.1 United States
- 10.1.1 United States: US Esoteric Testing Market – Revenue
and Forecast to 2030 (US$ Billion)
- 10.1.1.1 United States:
US Esoteric Testing Market Breakdown, by Type
- 10.1.1.2 United States:
US Esoteric Testing Market Breakdown, by Technology
- 10.1.1.3 United States:
US Esoteric Testing Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Georgia Esoteric & Molecular Laboratory LLC
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Laboratory Corp of America Holdings
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Quest Diagnostics Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 National Medical Services Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 OPKO Health Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 ARUP Laboratories Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 bioMONTR Labs
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Athena Esoterix LLC
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Stanford Hospital & Clinics
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Foundation Medicine Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations